{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:45:25Z","timestamp":1764603925367},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"DOI":"10.7759\/cureus.32227","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T23:24:30Z","timestamp":1670282670000},"source":"Crossref","is-referenced-by-count":4,"title":["A Suspected Case of COVID-19-Induced Immunosuppression"],"prefix":"10.7759","author":[{"given":"Kofi","family":"Seffah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter Y","family":"Agyeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li Q","year":"2020","unstructured":"Li Q, Guan X, Wu P, et al.. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020, 382:1199-207. 10.1056\/NEJMoa2001316","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue ML","year":"2020","unstructured":"Holshue ML, DeBolt C, Lindquist S, et al.. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020, 382:929-36. 10.1056\/NEJMoa2001191","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181:271-280.e8. 10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01516-2","article-title":"COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics","volume":"49","author":"Yesudhas D","year":"2021","unstructured":"Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection. 2021, 49:199-213. 10.1007\/s15010-020-01516-2","journal-title":"Infection"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze JL","year":"2021","unstructured":"Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021, 184:1671-92. 10.1016\/j.cell.2021.02.029","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta A","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020, 26:1017-32. 10.1038\/s41591-020-0968-3","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.05.106","article-title":"Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity","volume":"97","author":"Kang CK","year":"2020","unstructured":"Kang CK, Han GC, Kim M, et al.. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020, 97:313-21. 10.1016\/j.ijid.2020.05.106","journal-title":"Int J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0454-3","article-title":"Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?","volume":"17","author":"Zhang C","year":"2020","unstructured":"Zhang C, Wang FS, Silvestre JS, Arenzana-Seisdedos F, Tang H. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?. Cell Mol Immunol. 2020, 17:675-6. 10.1038\/s41423-020-0454-3","journal-title":"Cell Mol Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25900","article-title":"High IL-6\/IFN-\u03b3 ratio could be associated with severe disease in COVID-19 patients","volume":"92","author":"Lagunas-Rangel FA","year":"2020","unstructured":"Lagunas-Rangel FA, Ch\u00e1vez-Valencia V. High IL-6\/IFN-\u03b3 ratio could be associated with severe disease in COVID-19 patients. J Med Virol. 2020, 92:1789-90. 10.1002\/jmv.25900","journal-title":"J Med Virol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh C","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, et al.. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022, 23:210-6. 10.1038\/s41590-021-01113-x","journal-title":"Nat Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldh043","article-title":"Cryptococcal meningitis","volume":"72","author":"Bicanic T","year":"2004","unstructured":"Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull. 2004, 72:99-118. 10.1093\/bmb\/ldh043","journal-title":"Br Med Bull"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-011-9473-z","article-title":"Ten challenges on Cryptococcus and cryptococcosis","volume":"173","author":"Del Poeta M","year":"2012","unstructured":"Del Poeta M, Casadevall A. Ten challenges on Cryptococcus and cryptococcosis. Mycopathologia. 2012, 173:303-10. 10.1007\/s11046-011-9473-z","journal-title":"Mycopathologia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2459-9","article-title":"Disseminated cryptococcosis with recurrent multiple abscesses in an immunocompetent patient: a case report and literature review","volume":"17","author":"Ruan Q","year":"2017","unstructured":"Ruan Q, Zhu Y, Chen S, Zhu L, Zhang S, Zhang W. Disseminated cryptococcosis with recurrent multiple abscesses in an immunocompetent patient: a case report and literature review. BMC Infect Dis. 2017, 17:369. 10.1186\/s12879-017-2459-9","journal-title":"BMC Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system","volume":"9","author":"Voelz K","year":"2010","unstructured":"Voelz K, May RC. Cryptococcal interactions with the host immune system. Eukaryot Cell. 2010, 9:835-46. 10.1128\/EC.00039-10","journal-title":"Eukaryot Cell"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2003.03011","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)","volume":"30","author":"Ahn DG","year":"2020","unstructured":"Ahn DG, Shin HJ, Kim MH, et al.. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol. 2020, 30:313-24. 10.4014\/jmb.2003.03011","journal-title":"J Microbiol Biotechnol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.03.006","article-title":"Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients","volume":"118","author":"Chan Sui Ko A","year":"2022","unstructured":"Chan Sui Ko A, Candellier A, Mercier M, Joseph C, Schmit JL, Lanoix JP, Andrejak C. Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients. Int J Infect Dis. 2022, 118:220-3. 10.1016\/j.ijid.2022.03.006","journal-title":"Int J Infect Dis"},{"key":"ref17","unstructured":"National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. (2020). Accessed: July 12, 2022: https:\/\/www.nice.org.uk\/guidance\/ng188."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6213450","article-title":"Predictors of COVID-19 infection: a prevalence study of hospitalized patients","volume":"2021","author":"Tu H","year":"2021","unstructured":"Tu H, Zhao H, Su J, et al.. Predictors of COVID-19 infection: a prevalence study of hospitalized patients. Can J Infect Dis Med Microbiol. 2021, 2021:6213450. 10.1155\/2021\/6213450","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27635","article-title":"Cryptococcus infection in an immunocompetent patient","volume":"14","author":"Seffah K","year":"2022","unstructured":"Seffah K, Agyeman W, Madeo JL, Ahmad A. Cryptococcus infection in an immunocompetent patient. Cureus. 2022, 14:e27635. 10.7759\/cureus.27635","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127034-a-suspected-case-of-covid-19-induced-immunosuppression","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:16Z","timestamp":1707507856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127034-a-suspected-case-of-covid-19-induced-immunosuppression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.32227","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,5]]}}}